April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Gene delivery of GRP78/BiP promotes retinal ganglion cell survival following optic nerve crush
Author Affiliations & Notes
  • Yang Liu
    North Texas Eye Research Institute, For Worth, TX
    Cell Biology and Immunology, UNT Health Science Center, Fort Worth, TX
  • Tasneem Putliwala Sharma
    North Texas Eye Research Institute, For Worth, TX
    Cell Biology and Immunology, UNT Health Science Center, Fort Worth, TX
  • Robert J Wordinger
    North Texas Eye Research Institute, For Worth, TX
    Cell Biology and Immunology, UNT Health Science Center, Fort Worth, TX
  • Marina S Gorbatyuk
    North Texas Eye Research Institute, For Worth, TX
    Cell Biology and Immunology, UNT Health Science Center, Fort Worth, TX
  • Abbot F Clark
    North Texas Eye Research Institute, For Worth, TX
    Cell Biology and Immunology, UNT Health Science Center, Fort Worth, TX
  • Footnotes
    Commercial Relationships Yang Liu, None; Tasneem Sharma, None; Robert Wordinger, None; Marina Gorbatyuk, None; Abbot Clark, Alcon Res, Ltd. (F), Sanofi-FOVEA (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2426. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yang Liu, Tasneem Putliwala Sharma, Robert J Wordinger, Marina S Gorbatyuk, Abbot F Clark; Gene delivery of GRP78/BiP promotes retinal ganglion cell survival following optic nerve crush. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2426.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Optic nerve injury triggers endoplasmic reticulum (ER) stress and activates the unfolded protein response (UPR), leading to retinal ganglion cell (RGC) degeneration. Glucose-regulated protein (GRP78/BiP) is a sensor of ER homeostasis and plays a role in ER stress alleviation. In this study, we evaluated the involvement of GRP78/BiP in RGC degeneration induced by optic nerve crush (ONC) and the neuroprotective effects of gene delivery of GRP78/BiP.

Methods: ONC was performed unilaterally in adult BALB/cJ mice. The expression of GRP78/BiP was evaluated by real time PCR and fluorescent in situ hybridization (FISH). To evaluate the potential neuroprotective effect of BiP , an AAV2 vector harboring the human BiP gene (AAV2-hBiP) or green fluorescent protein (AAV2-GFP) (2 x 10^9 P) was intravitreally injected 4 weeks prior to the ONC. Seven and fourteen days after the ONC, RGC survival was determined by RBPMS immunofluorescence staining of retinal flat mounts. Retinal function was assessed using full field flash ERG. Expression of UPR related proteins was evaluated by western blotting.

Results: Three days after ONC, GRP78/BiP expression was significantly up-regulated in RGCs (p<0.01). Intravitreal administration of AAV2-hBiP significantly reduced RGC loss at 7 and 14 days post-ONC compared to AAV2-GFP injected group (n=5, p<0.01). ERG analysis showed partial protection of pSTR amplitudes in AAV2-hBiP injected eyes (n=5, p<0.05). Retina levels of cleaved ATF6 in AAV2-hBiP injected eyes were much lower than those of AAV2-GFP injected eyes.

Conclusions: Gene delivery of GRP78/BiP promotes RGC survival and preserves RGC function following optic nerve injury. This study suggests a potential therapeutic target for central nervous system neurodegenerative diseases.

Keywords: 615 neuroprotection • 531 ganglion cells • 538 gene transfer/gene therapy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×